- Home
- CPRX vs CENTA Comparison
CPRX vs CENTA Comparison
Compare CPRX & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- CENTA
- Stock Information
- Founded
- CPRX 2002
- CENTA 1955
- Country
- CPRX United States
- CENTA United States
- Employees
- CPRX N/A
- CENTA N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- CENTA Consumer Specialties
- Sector
- CPRX Health Care
- CENTA Consumer Discretionary
- Exchange
- CPRX Nasdaq
- CENTA Nasdaq
- Market Cap
- CPRX 2.6B
- CENTA 2.1B
- IPO Year
- CPRX 2006
- CENTA 1993
- Fundamental
- Price
- CPRX $20.02
- CENTA $32.13
- Analyst Decision
- CPRX Strong Buy
- CENTA Buy
- Analyst Count
- CPRX 5
- CENTA 4
- Target Price
- CPRX $33.20
- CENTA $37.00
- AVG Volume (30 Days)
- CPRX 1.5M
- CENTA 338.0K
- Earning Date
- CPRX 11-05-2025
- CENTA 08-06-2025
- Dividend Yield
- CPRX N/A
- CENTA N/A
- EPS Growth
- CPRX 183.96
- CENTA N/A
- EPS
- CPRX 1.65
- CENTA 2.14
- Revenue
- CPRX $558,499,000.00
- CENTA $3,120,375,000.00
- Revenue This Year
- CPRX $16.51
- CENTA N/A
- Revenue Next Year
- CPRX $9.58
- CENTA $0.16
- P/E Ratio
- CPRX $12.10
- CENTA $15.37
- Revenue Growth
- CPRX 28.55
- CENTA N/A
- 52 Week Low
- CPRX $19.15
- CENTA $27.70
- 52 Week High
- CPRX $26.58
- CENTA $37.35
- Technical
- Relative Strength Index (RSI)
- CPRX 46.35
- CENTA 41.60
- Support Level
- CPRX $19.66
- CENTA $31.85
- Resistance Level
- CPRX $20.52
- CENTA $34.88
- Average True Range (ATR)
- CPRX 0.67
- CENTA 0.78
- MACD
- CPRX 0.03
- CENTA -0.11
- Stochastic Oscillator
- CPRX 42.08
- CENTA 9.24
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About CENTA Central Garden & Pet Company Nonvoting
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.